Development of EGFR TKIs and Options to Manage Resistance of Third-Generation EGFR TKI Osimertinib: Conventional Ways and Immune Checkpoint Inhibitors.

EGFR TKI resistance combination (combined) therapy immune check inhibitor mechanisms of resistance molecular biomarkers osimertinib tumor immune environment

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2020
Historique:
received: 07 09 2020
accepted: 09 11 2020
entrez: 4 1 2021
pubmed: 5 1 2021
medline: 5 1 2021
Statut: epublish

Résumé

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) have been first-line therapy in the treatment of non-small cell lung cancer (NSCLC) harboring

Identifiants

DOI: 10.3389/fonc.2020.602762 PMID: 33392095 PMC: PMC7775519
pubmed: 33392095
doi: 10.3389/fonc.2020.602762
pmc: PMC7775519
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

602762

Informations de copyright

Copyright © 2020 Wu, Ke, Zhang, Yu and Meng.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Clin Oncol. 2018 Mar 20;36(9):911-919
pubmed: 29401004
J Clin Oncol. 2016 Sep 1;34(25):2980-7
pubmed: 27354485
Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S17-27
pubmed: 16113093
Thorac Cancer. 2018 Jul;9(7):856-864
pubmed: 29761660
Oncogene. 2017 Mar 23;36(12):1721-1732
pubmed: 27641338
Clin Lung Cancer. 2015 Sep;16(5):e25-35
pubmed: 25801750
Lung Cancer. 2019 Apr;130:59-66
pubmed: 30885353
N Engl J Med. 2018 Jun 14;378(24):2288-2301
pubmed: 29863955
Lung Cancer. 2014 Aug;85(2):101-9
pubmed: 24880938
J Thorac Oncol. 2017 Jul;12(7):1061-1070
pubmed: 28428148
Lancet Oncol. 2017 Jan;18(1):31-41
pubmed: 27932067
Cancer Discov. 2020 Aug;10(8):1194-1209
pubmed: 32414908
Lancet Oncol. 2012 May;13(5):539-48
pubmed: 22452895
Oncotarget. 2017 Dec 8;9(4):4637-4646
pubmed: 29435131
Lancet Oncol. 2019 Dec;20(12):1681-1690
pubmed: 31587882
Lancet Respir Med. 2017 Nov;5(11):891-902
pubmed: 29056570
J Thorac Oncol. 2018 Nov;13(11):1668-1675
pubmed: 30056164
Ann N Y Acad Sci. 2010 Apr;1194:169-78
pubmed: 20536466
J Thorac Oncol. 2015 Dec;10(12):1736-44
pubmed: 26473643
JAMA Oncol. 2018 Aug 1;4(8):1112-1115
pubmed: 29327061
J Thorac Oncol. 2016 Mar;11(3):414-9
pubmed: 26723242
J Clin Oncol. 2017 Dec 20;35(36):4027-4034
pubmed: 28968167
Nat Commun. 2019 Jan 16;10(1):259
pubmed: 30651547
JAMA Oncol. 2016 Apr;2(4):541-3
pubmed: 26720284
Cancer Lett. 2017 Jan 28;385:51-54
pubmed: 27840244
J Thorac Oncol. 2014 Feb;9(2):154-62
pubmed: 24419411
J Clin Oncol. 2017 Aug 20;35(24):2781-2789
pubmed: 28609226
J Thorac Oncol. 2015 Jan;10(1):156-63
pubmed: 25247337
Nature. 2014 Jul 31;511(7511):543-50
pubmed: 25079552
Lung Cancer. 2017 Mar;105:17-22
pubmed: 28236980
Nat Med. 2015 Jun;21(6):560-2
pubmed: 25939061
Cancer Discov. 2019 Jul;9(7):926-943
pubmed: 31092401
Med Oncol. 2015 Jul;32(7):205
pubmed: 26081015
Clin Cancer Res. 2013 Apr 15;19(8):2240-7
pubmed: 23470965
J Thorac Oncol. 2020 Jan;15(1):50-61
pubmed: 31557536
J Thorac Oncol. 2018 Sep;13(9):1363-1372
pubmed: 29802888
Nature. 2009 Dec 24;462(7276):1070-4
pubmed: 20033049
N Engl J Med. 2015 Apr 30;372(18):1689-99
pubmed: 25923549
N Engl J Med. 2018 Jan 11;378(2):113-125
pubmed: 29151359
Lancet. 2016 Apr 2;387(10026):1415-1426
pubmed: 26777916
Cancer Res. 2017 Jun 1;77(11):2990-3000
pubmed: 28416483
Clin Cancer Res. 2018 Dec 15;24(24):6195-6203
pubmed: 30228210
Lancet Oncol. 2018 Apr;19(4):521-536
pubmed: 29545095
Ann Oncol. 2016 Sep;27(suppl 5):v1-v27
pubmed: 27664245
Cancer Treat Rev. 2018 Apr;65:1-10
pubmed: 29477930
Clin Cancer Res. 2016 Oct 1;22(19):4837-4847
pubmed: 27252416
Clin Cancer Res. 2018 Jun 1;24(11):2594-2604
pubmed: 29298799
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
Lancet Oncol. 2015 Jul;16(7):830-8
pubmed: 26051236
N Engl J Med. 2009 Sep 3;361(10):958-67
pubmed: 19692684
J Thorac Oncol. 2018 Aug;13(8):1138-1145
pubmed: 29874546
J Thorac Oncol. 2015 May;10(5):793-799
pubmed: 25668120
Lancet Oncol. 2020 Mar;21(3):373-386
pubmed: 32027846
Cancer Lett. 2016 Oct 1;380(2):494-504
pubmed: 27450722
J Exp Clin Cancer Res. 2017 Dec 04;36(1):174
pubmed: 29202823
Cancer Cell. 2014 Mar 17;25(3):282-303
pubmed: 24651011
Lancet Oncol. 2015 Aug;16(8):990-8
pubmed: 26159065
Cancer Chemother Pharmacol. 2018 Apr;81(4):679-686
pubmed: 29442139
Br J Cancer. 2015 Jan 6;112(1):95-102
pubmed: 25349974
Transl Lung Cancer Res. 2019 Nov;8(Suppl 3):S247-S264
pubmed: 31857949
N Engl J Med. 2017 Feb 16;376(7):629-640
pubmed: 27959700
Oncogene. 2019 Jan;38(4):455-468
pubmed: 30111817
Clin Cancer Res. 2016 Mar 1;22(5):1103-10
pubmed: 26446944
N Engl J Med. 2017 Dec 21;377(25):2500-2501
pubmed: 29262275
Clin Cancer Res. 2019 Apr 15;25(8):2575-2587
pubmed: 30670498
N Engl J Med. 2019 Nov 21;381(21):2020-2031
pubmed: 31562796
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E6030-E6038
pubmed: 29875142
Nature. 2016 May 25;534(7605):129-32
pubmed: 27251290
Sci Transl Med. 2011 Mar 23;3(75):75ra26
pubmed: 21430269
Lung Cancer. 2014 Nov;86(2):170-3
pubmed: 25214431
Genes Cancer. 2017 Mar;8(3-4):497-504
pubmed: 28680534
Ann Oncol. 2017 Jul 1;28(7):1532-1539
pubmed: 28407039
Cancer Discov. 2015 Jul;5(7):713-22
pubmed: 25934077
Cancers (Basel). 2018 Aug 14;10(8):
pubmed: 30110953
Int J Cancer. 2006 Jan 15;118(2):257-62
pubmed: 16231326
Ann Oncol. 2016 May;27(5):862-7
pubmed: 26823523
Lung Cancer. 2017 Jun;108:238-241
pubmed: 28625643
Oncotarget. 2016 Nov 29;7(48):78985-78993
pubmed: 27738317
J Thorac Oncol. 2017 Feb;12(2):403-407
pubmed: 27765535
J Clin Oncol. 2019 Oct 1;37(28):2518-2527
pubmed: 31154919
J Natl Cancer Inst. 2005 Mar 2;97(5):339-46
pubmed: 15741570
J Clin Oncol. 2020 Feb 10;38(5):488-495
pubmed: 31825714
N Engl J Med. 2015 Apr 30;372(18):1700-9
pubmed: 25923550
JAMA Oncol. 2018 Feb 1;4(2):210-216
pubmed: 29270615
Cancer Discov. 2013 Dec;3(12):1355-63
pubmed: 24078774
Cancer Lett. 2018 Apr 28;420:242-246
pubmed: 29425688
Mol Cell Oncol. 2015 Apr 01;2(3):e985549
pubmed: 27308463
Clin Lung Cancer. 2017 Nov;18(6):719-723
pubmed: 28623122
Clin Cancer Res. 2015 Sep 1;21(17):3924-33
pubmed: 25964297
JAMA Oncol. 2018 Nov 1;4(11):1527-1534
pubmed: 30073261
J Immunother Cancer. 2020 Jun;8(1):
pubmed: 32606052

Auteurs

Leilei Wu (L)

Department of Radiation Oncology, School of Medicine, Shandong University, Jinan, China.
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Linping Ke (L)

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Zhenshan Zhang (Z)

Department of Radiation Oncology, School of Medicine, Shandong University, Jinan, China.

Jinming Yu (J)

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Xue Meng (X)

Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.

Classifications MeSH